Actively Recruiting
A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
Led by Mayo Clinic · Updated on 2026-04-17
60
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).
CONDITIONS
Official Title
A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 75 years
- Diagnosed with Persistent Postural-Perceptual Dizziness (PPPD) according to International Classification of Vestibular Disorders
- Persistent dizziness lasting 3 months or more
- At least one dizziness exacerbation per day during a 2-week run-in period
- On stable medications or therapy for at least 4 weeks prior to baseline, if any
You will not qualify if you...
- Uncompensated peripheral or central vestibular deficit, sensory-afferent or cerebellar ataxia
- Cardiac disease such as coronary disease or unstable arrhythmia
- Recurrent syncope with more than one episode in the past 12 months
- History of neck surgery, vagotomy, or any condition interfering with vagal stimulation
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
Actively Recruiting
Research Team
C
Colton Clayton, Au.D., Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here